Trial intelligence / Profile preview

BMAC/Collagen vs Autograft for Immediate Implants

NCT05817526Recruiting

Sponsor
Cairo University
Start
Jan 2023
Primary completion
Oct 2024
Modality
Stem Cell Therapies
Countries
1
01

Overview

Randomised trial of autologous bone marrow cell concentrate in peri-implantitis (2 arms), sponsored by Cairo University. Primary endpoint: Marginal bone changes at 4 months. Started Jan 2023; status: recruiting.

02

Drugs

autologous bone marrow cell concentrate
03

Conditions

peri-implantitis

Beyond the preview

Go deeper on NCT05817526.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05817526.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call